Research led by the Centenary Institute in Sydney has found a brand new target for treating drug resistant tuberculosis; our scientists have uncovered that the tuberculosis bacterium hijacks platelets from the body’s blood clotting system to weaken our immune systems.
Tuberculosis is far from eradicated around the world and still infects more than 1,400 people per year in Australia. Antibiotic resistant tuberculosis is particularly deadly and expensive to treat,
costing up to $250,000 to treat a single case in Australia. Scientists at the Centenary Institute have been working on new ways to treat tuberculosis by increasing the effectiveness of the immune
Using the zebrafish model of tuberculosis, the researchers used fluorescent microscopy to observe the build-up of clots and activation of platelets around sites of infection . Senior author and head of the Centenary’s Immune-Vascular Interactions laboratory, Dr Stefan Oehlers, says “the zebrafish gives us literal insight into disease processes by watching cells interacting in real time”.
Following their hunch that these platelets were being tricked by the infection into getting in the way of the body’s immune system, the researchers treated infections with anti-platelet drugs, including widely available aspirin, and were able to prevent hijacking and allow the body to control infection better.
Dr Elinor Hortle, lead author of the paper published in The Journal of Infectious Diseases, and Research Officer in Centenary’s Immune-Vascular Interactions laboratory says “This is the first
time that platelets have been found to worsen tuberculosis in an animal model. It opens up the possibility that anti-platelet drugs could be used to help the immune system fight off drug resistant
There are over 1.2 million Australians living with latent tuberculosis, a non-infectious form of TB that puts them at risk of developing the active disease. “Our study provides more crucial evidence
that widely available aspirin could be used to treat patients with severe tuberculosis infection and save lives,” says Dr Hortle.
Video 1 – Green platelets
zooming around the
vasculature of a zebrafish
embryo. Note some platelets
stick to red macrophages
infected by blue bacteria
Video 2 – Zoomed in version
of video 1 with visible blood
Green platelets sticking to
red blood vessels next to
sites of infection by blue
bacteria. Pathogenic platelets
are the green cells that stick
next to the bacteria for a few
The Latest on: Tuberculosis
via Google News
The Latest on: Tuberculosis
- Elephants at Tacoma zoo with tuberculosis won’t be treatedon November 15, 2019 at 3:03 am
TACOMA, Wash. — The two Asian elephants at Point Defiance Zoo & Aquarium have tested positive for tuberculosis, according to zoo officials. Head zoo veterinarian Dr. Karen Wolf said elephants Hanako ...
- Hundreds tested over tuberculosis diagnosis at SC med centeron November 15, 2019 at 2:36 am
Hundreds of people have been screened for tuberculosis after possible exposure to a patient recently diagnosed with the contagious disease. Lexington Medical Center spokeswoman Jennifer Wilson says ...
- 3 cases of tuberculosis reported in San Diego Countyon November 14, 2019 at 10:13 pm
SAN DIEGO — Three unrelated cases of tuberculosis have been reported in San Diego County, including one person who later died from co-occurring medical conditions, health officials announced Thursday.
- Elephants at Point Defiance Zoo test positive for tuberculosison November 14, 2019 at 6:16 pm
2 elephants at the Point Defiance Zoo tested positive for tuberculosis, but treating it may compromise their immune systems. Zoogoers are not at risk.
- Low clinical value in repeat latent tuberculosis tests in patients taking biologicson November 14, 2019 at 7:21 am
ATLANTA — Repeat, routine testing for latent tuberculosis infection among patients receiving biologics is both costly and of low clinical value, according to findings presented at the 2019 ACR/ARP ...
- BCG Tuberculosis (TB) Vaccine Market is Booming Worldwideon November 14, 2019 at 12:48 am
Nov 14, 2019 (Market Prediction via COMTEX) -- The latest trending report Global BCG Tuberculosis (TB) Vaccine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2026 offered by ...
- Auburn hospital says 26 infants, 27 adult patients possibly exposed to tuberculosison November 13, 2019 at 11:11 am
Officials at a hospital in Auburn said they are contacting 27 adult patients and the families of 26 infants to recommend testing for tuberculosis. The recommendation also extends to visitors who had ...
- Hospital says 26 infants, 27 adult patients possibly exposed to tuberculosison November 13, 2019 at 11:06 am
Related Video: Medical Officer Discusses Tuberculosis Exposure at Hospital in Auburn, Wash. (Provided by KING-TV Seattle) Officials at a hospital in Auburn, Wash., said they are contacting 27 adult ...
- Anti-tuberculosis Therapeutics Market SWOT Analysis by Key Players: Lupin, Pfizer, Novartison November 13, 2019 at 6:34 am
Nov 13, 2019 (HTF Market Intelligence via COMTEX) -- A new market study is released on Global Anti-tuberculosis Therapeutics Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread ...
- SeeTB: A novel alternative to sputum smear microscopy to diagnose tuberculosis in high burden countrieson November 12, 2019 at 4:48 am
Microscopy-based tuberculosis (TB) diagnosis i.e. Ziehl-Neelsen screening still remains the primary diagnostic method in resource poor and high TB burden countries, however this method has poor ...
via Bing News